PLAINSBORO, N.J., Nov 14, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a world leader in regenerative medicine, announced today that it has been selected by Medical Device & Diagnostic Industry (MD&DI) magazine as a "2007 Medical Device Manufacturer of the Year." Integra was selected for its innovative medical devices, commitment to research, market success, and its impressive quality and regulatory record. The announcement was made in the November issue of MD&DI.

"We are very pleased that MD&DI has recognized Integra's substantial growth and accomplishments," said Integra's President and CEO Stuart Essig. "Integra is dedicated to bringing the best possible medical products to the market and we're committed to quality -- it's at the core of our philosophy and pervades our entire organization. This honor is truly the result of the hard work of our employees, and together we have created a very successful organization that helps millions of patients."

Since Integra's inception in 1989, Integra has grown from a company with one product -- an artificial skin, used in wound and burn care, called Integra(R) Dermal Regeneration Template -- to a company with thousands of medical devices and instruments. Today, Integra is a market leader in neurosurgery and has embarked on a similar course to become a major company in the hand, foot and ankle sector of the orthopedics market.

"When the editors of MD&DI select our Medical Manufacturers of the Year, we always look for a good success story," said Erik Swain, editor-in-chief, MD&DI. "Integra LifeSciences more than fits the bill. I first encountered Integra in 1997, when it was a small company with an innovative artificial-skin technology. When it was suggested that MD&DI consider Integra for the 2007 Medical Manufacturer of the Year, we knew it should receive strong consideration, but we were pleasantly surprised at just how far it had come in 10 years. And we could tell it had a story that our readers would want to hear."

Earlier this year, Integra was named as the New Jersey Technology Council's Master Technology Company of the Year, and was included in Deloitte & Touche USA LLP's Technology Fast 50 Program for New Jersey.

Medical Device & Diagnostic Industry is a monthly magazine written exclusively for original equipment manufacturers of medical devices and in vitro diagnostic products. To view the full article in the November issue visit http://www.devicelink.com/mddi/archive/07/11/003.html

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. The company's products are used to treat millions of patients every year, primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery. Integra's headquarters are in Plainsboro, New Jersey, and it has research and manufacturing facilities throughout the world. www.Integra-LS.com.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning expectations for Integra's future growth and investments in its neurosurgery and orthopedics businesses. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, Integra's ability to successfully achieve its goals for these businesses could affect Integra's future financial results. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in section IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2006 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.

IART-G

This news release was distributed by PrimeNewswire, www.primenewswire.com

SOURCE: Integra LifeSciences Holdings Corp.

Integra LifeSciences Holdings Corporation
         John B. Henneman, III, Executive Vice President,
          Chief Administrative Officer,
          Acting Chief Financial Officer     
           (609) 936-2481                     
           jhenneman@Integra-LS.com 
         Gianna Sabella, Public Relations Manager                  
           (609) 936-2389                   
           gsabella@integra-LS.com

(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.

News Provided by COMTEX